<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Central sympathetic activation with increased release of <z:chebi fb="15" ids="33569">noradrenaline</z:chebi> occurs during <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>, but it is not certain how the increased sympathetic activity affects neuronal damage </plain></SENT>
<SENT sid="1" pm="."><plain>We have studied the effect of <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi>, a potent alpha 2-<z:chebi fb="0" ids="37886">adrenergic receptor agonist</z:chebi> that reduces the central release of <z:chebi fb="15" ids="33569">noradrenaline</z:chebi>, on neuronal damage after 10 min of severe forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in the rat </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischaemia</z:e> was achieved by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> combined with <z:mp ids='MP_0001914'>bleeding</z:mp> to a mean arterial pressure of 50 mmHg </plain></SENT>
<SENT sid="3" pm="."><plain>The post-ischaemic neuronal damage was most pronounced in the hippocampal CA1 region (median percentage of necrotic cells 36% (11-69%) and 42% (11-68%) in the <z:chebi fb="0" ids="4466">dexmedetomidine</z:chebi> and vehicle groups, respectively) and in the subiculum </plain></SENT>
<SENT sid="4" pm="."><plain>The reticular thalamic nucleus was moderately damaged in <z:hpo ids='HP_0000001'>all</z:hpo> but one rat, while the rest of the thalamus was almost spared </plain></SENT>
<SENT sid="5" pm="."><plain>Most rats had mild to moderate damage in cortex and caudoputamen </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="4466">Dexmedetomidine</z:chebi> did not affect the neuronal outcome in this model </plain></SENT>
</text></document>